Earnings History Data for Relay Therapeutics, Inc. (RLAY) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Relay Therapeutics, Inc.
Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | AH | RLAY | Relay Therapeutics, Inc. | 783.26 | -0.63 | -0.77 | -0.54 | Relay Therapeutics GAAP EPS of -$0.63 beats by $0.14, revenue of $0M misses by $0.08M [11/6/2024 4:31 PM] |
6.14 | -0.11 (-1.68%) |
6.16 | -0.09 (-1.44%) |
5.60 - 12.14 | 1,458,101 | 1,340,000 | 64,806 | ||
| 06-08-2024 | AH | RLAY | Relay Therapeutics, Inc. | 1,060 | -0.69 | -0.72 | -0.81 | Relay Therapeutics GAAP EPS of -$0.69 beats by $0.04 [8/6/2024 4:41 PM] |
6.71 | -0.48 (-6.68%) |
7.19 | 0.0 (0.00%) |
5.70 - 12.19 | 1,388,399 | 1,020,000 | 3,713 | ||
| 02-05-2024 | AH | RLAY | Relay Therapeutics, Inc. | 864.47 | -0.62 | -0.70 | -0.78 | Relay Therapeutics GAAP EPS of -$0.62 beats by $0.08, revenue of $10M beats by $9.89M [5/2/2024 4:25 PM] |
7.04 | -0.04 (-0.49%) |
7.76 | 0.68 (9.60%) |
5.70 - 13.32 | 930,745 | 1,220,000 | 672 | ||
| 22-02-2024 | AH | RLAY | Relay Therapeutics, Inc. | 1,340 | -0.67 | -0.71 | -0.56 | 9.95 | -0.62 (-5.87%) |
10.89 | 0.32 (3.03%) |
5.95 - 19.54 | 2,163,497 | 1,330,000 | 516 | |||
|
|
||||||||||||||||||
| 02-11-2023 | PM | RLAY | Relay Therapeutics, Inc. | 806.08 | -0.54 | -0.83 | -0.76 | Relay Therapeutics GAAP EPS of -$0.54, revenue of $25.2M [11/3/2023 1:07 AM] |
7.51 | 0.11 (1.55%) |
8.18 | 0.78 (10.54%) |
5.95 - 23.18 | 1,521,504 | 1,260,000 | 4,228 | ||
| 08-08-2023 | AH | RLAY | Relay Therapeutics, Inc. | 1,370 | -0.81 | -0.78 | -0.71 | Relay Therapeutics GAAP EPS of -$0.81 beats by $0.01, revenue of $0.12M misses by $0.59M [8/8/2023 4:32 PM] |
11.14 | -0.03 (-0.22%) |
11.17 | 0.0 (0.00%) |
9.67 - 33.06 | 858,139 | 850,000 | 15,075 | ||
| 04-05-2023 | AH | 4:05 PM ET (May 4) |
RLAY | Relay Therapeutics, Inc. | 1,270 | -0.78 | -0.70 | -0.61 | Relay Therapeutics GAAP EPS of -$0.78 misses by $0.09, revenue of $0.22M beats by $0.06M [5/4/2023 6:07 PM] |
11.25 | 0.03 (0.27%) |
10.71 | -0.51 (-4.55%) |
10.40 - 33.06 | 1,410,009 | 1,560,000 | 826 | |
| 23-02-2023 | AH | 4:05 PM ET (Feb 23) |
RLAY | Relay Therapeutics, Inc. | 2,230 | -0.56 | -0.68 | 0.36 | Relay Therapeutics GAAP EPS of -$0.56 beats by $0.14, revenue of $0.25M beats by $0.08M [2/23/2023 4:33 PM] |
17.02 | -0.41 (-2.35%) |
17.43 | 0.0 (0.00%) |
12.65 - 35.36 | 700,016 | 980,000 | 19,164 | |
| 03-11-2022 | AH | 4:05 PM ET (Nov 3) |
RLAY | Relay Therapeutics, Inc. | 2,700 | -0.76 | -0.71 | -0.66 | 20.53 | -0.41 (-1.96%) |
20.84 | -0.10 (-0.48%) |
12.65 - 37.52 | 604,526 | 640,000 | 100 | ||
|
|
||||||||||||||||||
| 04-08-2022 | AH | 4:05 PM ET (Aug 4) |
RLAY | Relay Therapeutics, Inc. | 2,300 | -0.71 | -0.62 | -2.10 | Relay Therapeutics GAAP EPS of -$0.71, revenue of $0.37M [8/4/2022 4:49 PM] |
19.73 | 0.57 (2.97%) |
19.73 | 0.0 (0.00%) |
12.65 - 38.15 | 1,581,530 | 720,000 | 3,276 | |
| 05-05-2022 | AH | 4:05 PM ET (May 5) |
RLAY | Relay Therapeutics, Inc. | 2,680 | -0.61 | -0.63 | -0.47 | Relay Therapeutics GAAP EPS of -$0.57 beats by $0.05, revenue of $0.42M [5/5/2022 4:52 PM] |
20.63 | -2.67 (-11.46%) |
20.63 | 0.0 (0.00%) |
19.05 - 38.60 | 2,212,322 | 610,000 | 325 | |
| 24-02-2022 | AH | 4:05 PM ET (Feb 24) |
RLAY | Relay Therapeutics, Inc. | 2,280 | 0.36 | -0.60 | 0.00 | Relay Therapeutics GAAP EPS of -$3.82, revenue of $3.03M [2/24/2022 4:45 PM] |
22.37 | 0.67 (3.09%) |
21.70 | 0.0 (0.00%) |
19.05 - 45.86 | 376,885 | 610,000 | 21,017 | |
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
RLAY | Relay Therapeutics, Inc. | 3,760 | -0.66 | -0.65 | 0.00 | Relay Therapeutics EPS misses by $0.01, beats on revenue [11/10/2021 4:52 PM] |
35.62 | 1.88 (5.56%) |
33.74 | 0.0 (0.00%) |
25.72 - 64.37 | 674,760 | 580,000 | 2,939 | |
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
RLAY | Relay Therapeutics, Inc. | 3,040 | -2.10 | -0.48 | -6.06 | Relay Therapeutics EPS misses by $1.64, misses on revenue [8/12/2021 4:35 PM] |
33.06 | -0.45 (-1.36%) |
33.52 | 0.0 (0.00%) |
26.44 - 64.37 | 1,757,467 | 390,000 | 42,811 | |